文献速递乳腺外科

美国乳腺肿瘤切除率趋势逆转分析(2005–2017):基于三个全国性数据集

Analysis of a Trend Reversal in US Lumpectomy Rates From 2005 Through 2017 Using 3 Nationwide Data Sets.
PubMed 文献 · JAMA Surg · 2022-01-01

该研究利用NSQIP、SEER和NCDB三个全国性数据集,分析2005至2017年美国女性乳腺癌患者乳腺肿瘤切除与乳房切除术的趋势。结果显示乳腺肿瘤切除率在2010至2013年间触底后显著上升,2013年后乳房切除术(含单侧和对侧预防性)下降或稳定。

要点

  • 2005至2013年乳腺肿瘤切除率年下降,2013至2017年年上升。
  • 2013年后单侧乳房切除术和对侧预防性乳房切除术率趋于稳定。
  • 整个研究期间单侧乳房切除术率始终高于对侧预防性乳房切除术率。

核心结论

  • 2013年以来乳腺肿瘤切除率出现趋势逆转并上升,乳房切除术相应下降。
  • 2005至2013年对侧预防性乳房切除术率持续上升后趋于稳定。

研究设计与样本

  • 观察性纵向分析,使用NSQIP、SEER和NCDB三个全国性数据集。
  • 研究样本为3 467 645例女性乳腺癌手术患者,时间跨度为2005至2017年。
  • 采用Cochran-Armitage趋势检验分析纵向趋势,并对NCDB数据行多因素logistic回归。

主要发现

  • 乳腺肿瘤切除率在2010至2013年间达到最低点,此后显著上升。
  • 2005至2013年,NSQIP、SEER和NCDB中乳腺肿瘤切除率年下降分别为1.31%(95%CI 1.30%-1.32%)、0.07%(95%CI 0.01%-0.12%)和0.15%(95%CI 0.15%-0.16%),P值分别<.001、=.01和<.001。
  • 2013至2017年,NSQIP、SEER和NCDB中乳腺肿瘤切除率年上升分别为0.96%(95%CI 0.95%-0.98%)、1.60%(95%CI 1.59%-1.62%)和1.66%(95%CI 1.65%-1.67%),所有P<.001。
  • 2013年后单侧乳房切除术和对侧预防性乳房切除术率趋于稳定,单侧乳房切除术率在整个期间均高于对侧预防性乳房切除术率。

临床怎么用

  • 关注2013年后乳腺肿瘤切除率上升的趋势,在临床决策中综合评估保乳手术与乳房切除术的适应证。
  • 对侧预防性乳房切除术率已趋于稳定,仍需个体化评估其对侧预防性切除的获益与风险。

局限性

  • 为观察性纵向分析,无法确定趋势逆转的原因。
  • 作者指出趋势逆转的原因可能是多因素的,需进一步定性和定量研究以理解驱动因素及与患者报告结局的关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Rates of lumpectomy for breast cancer management in the United States previously declined in favor of more aggressive surgical options, such as mastectomy and contralateral prophylactic mastectomy (CPM). OBJECTIVE: To evaluate longitudinal trends in the rates of lumpectomy and mastectomy, including unilateral mastectomy vs CPM rates, and to determine characteristics associated with current surgical practice using 3 national data sets. DESIGN AND SETTING: Data from the National Surgical Quality Improvement Program (NSQIP), Surveillance, Epidemiology, and End Results (SEER) program, and National Cancer Database (NCDB) were examined to evaluate trends in lumpectomy and mastectomy rates from 2005 through 2017. Mastectomy rates were also evaluated with a focus on CPM. Longitudinal trends were analyzed using the Cochran-Armitage test for trend. Multivariate logistic regression models were performed on the NCDB data set to identify predictors of lumpectomy and CPM. RESULTS: A study sample of 3 467 645 female surgical breast cancer patients was analyzed. Lumpectomy rates reached a nadir between 2010 and 2013, with a significant increase thereafter. Conversely, in comparison with lumpectomy rates, overall mastectomy rates declined significantly starting in 2013. Cochran-Armitage trend tests demonstrated an annual decrease in lumpectomy rates of 1.31% (95% CI, 1.30%-1.32%), 0.07% (95% CI, 0.01%-0.12%), and 0.15% (95% CI, 0.15%-0.16%) for NSQIP, SEER, and NCDB, respectively, from 2005 to 2013 (P < .001, P = .01, and P < .001, respectively). From 2013 to 2017, the annual increase in lumpectomy rates was 0.96% (95% CI, 0.95%-0.98%), 1.60% (95% CI, 1.59%-1.62%), and 1.66% (95% CI, 1.65%-1.67%) for NSQIP, SEER, and NCDB, respectively (all P < .001). Comparisons of specific mastectomy types showed that unilateral mastectomy and CPM rates stabilized after 2013, with unilateral mastectomy rates remaining higher than CPM rates throughout the entire time period. CONCLUSIONS: This observational longitudinal analysis indicated a trend reversal with an increase in lumpectomy rates since 2013 and an associated decline in mastectomies. The steady increase in CPM rates from 2005 to 2013 has since stabilized. The reasons for the recent reversal in trends are likely multifactorial. Further qualitative and quantitative research is required to understand the factors driving these recent practice changes and their associations with patient-reported outcomes.

来源:JAMA Surg,查看原文。版权归原作者所有。

引用

  1. Nelson JA, Rubenstein RN, Haglich K, et al. Analysis of a Trend Reversal in US Lumpectomy Rates From 2005 Through 2017 Using 3 Nationwide Data Sets. JAMA Surg. 2022. PMID: 35675047. doi:10.1001/jamasurg.2022.2065

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。